If the FDA follows through with the proposed guidelines, and they are not fatally twisted by pressure from the medical ...
The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...
BioStem remains committed to advancing evidence-based innovation in wound care through rigorous clinical research and real-world data analysis, supported by its proprietary BioRetain ® process and ...
Dr. Àlex Bayés Puig advances SYNGAP1 research with new SynGAP biomarker study funded by CURE SYNGAP1
CURE SYNGAP1, a 501(c)(3) organization, is proud to announce the award of a $25,000 grant to Dr. Àlex Bayés Puig, Group ...
The US Food and Drug Administration today published draft guidance designed to facilitate the use of Bayesian methodologies in clinical trials of drugs and biologics, helping drug developers make ...
BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal ...
WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...
The US Food and Drug Administration (FDA) is now “open to bayesian statistics,” contrasting this with the frequentist approach that the agency and the drug industry have historically relied on for ...
Gather AI has closed funding from former Salesforce CEO's firm Smith Point Capital. Its warehouse AI system doesn't just scan. It seeks out specific data.
Dilaton (EMD) holographic QCD model combined with Bayesian analysis to conduct a detailed investigation into the ...
The overwhelming amount of data collected from each basketball game presents teams with a challenge — and an opportunity. Ken Pomeroy and Evan Miyakawa are two of the leaders spearheading a drive to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results